{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:57:18Z","timestamp":1786985838809,"version":"build-2736575974"},"reference-count":109,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015511","name":"Savara Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015511","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ccm.2025.07.005","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T11:13:32Z","timestamp":1756120412000},"page":"633-647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pulmonary Alveolar Proteinosis"],"prefix":"10.1016","volume":"46","author":[{"given":"Francesco","family":"Bonella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Borie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccm.2025.07.005_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-019-0066-3","article-title":"Pulmonary alveolar proteinosis","volume":"5","author":"Trapnell","year":"2019","journal-title":"Nat. Rev. Dis. Primer"},{"key":"10.1016\/j.ccm.2025.07.005_bib2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1126\/science.8171324","article-title":"Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis","volume":"264","author":"Dranoff","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ccm.2025.07.005_bib3","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1073\/pnas.91.12.5592","article-title":"Granulocyte\/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology","volume":"91","author":"Stanley","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ccm.2025.07.005_bib4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.190.6.875","article-title":"Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte\/macrophage colony-stimulating factor","volume":"190","author":"Kitamura","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib5","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1164\/ajrccm.162.2.9910032","article-title":"Serological diagnosis of idiopathic pulmonary alveolar proteinosis","volume":"162","author":"Kitamura","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib6","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood-2003-05-1565","article-title":"High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis","volume":"103","author":"Uchida","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2025.07.005_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/thorax-2023-220040","article-title":"Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort","volume":"79","author":"Mabo","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2025.07.005_bib8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s10875-022-01250-4","article-title":"Pulmonary alveolar proteinosis and multiple infectious diseases in a child with autosomal recessive complete IRF8 deficiency","volume":"42","author":"Rosain","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ccm.2025.07.005_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1183\/09059180.00001311","article-title":"Pulmonary alveolar proteinosis","volume":"20","author":"Borie","year":"2011","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.ccm.2025.07.005_bib10","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ajhg.2015.03.010","article-title":"Biallelic mutations of Methionyl-tRNA synthetase cause a specific type of pulmonary alveolar proteinosis prevalent on R\u00e9union island","volume":"96","author":"Hadchouel","year":"2015","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ccm.2025.07.005_bib11","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1440-1843.2010.01848.x","article-title":"Alveolar proteinosis with hypersensitivity pneumonitis: a new clinical phenotype","volume":"15","author":"Verma","year":"2010","journal-title":"Respirol. Carlton Vic"},{"key":"10.1016\/j.ccm.2025.07.005_bib12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1378\/chest.08-2943","article-title":"Pulmonary alveolar proteinosis: a bench-to-bedside story of granulocyte-macrophage colony-stimulating factor dysfunction","volume":"136","author":"Greenhill","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2025.07.005_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/rccm.201001-0008OC","article-title":"Patient-derived granulocyte\/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates","volume":"182","author":"Sakagami","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib14","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1038\/s41467-018-05491-z","article-title":"Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis","volume":"9","author":"McCarthy","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ccm.2025.07.005_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1183\/09031936.00090610","article-title":"Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations","volume":"37","author":"Suzuki","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2025.07.005_bib16","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1172\/JCI119758","article-title":"Human pulmonary alveolar proteinosis associated with a defect in GM-CSF\/IL-3\/IL-5 receptor common beta chain expression","volume":"100","author":"Dirksen","year":"1997","journal-title":"J Clin Investig"},{"key":"10.1016\/j.ccm.2025.07.005_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/jmg.2010.082586","article-title":"Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB","volume":"48","author":"Tanaka","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.ccm.2025.07.005_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1164\/rccm.2109105","article-title":"Pulmonary alveolar proteinosis: progress in the first 44 years","volume":"166","author":"Seymour","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0761-8417(05)84811-4","article-title":"[Pulmonary alveolar phospholipoproteinosis]","volume":"61","author":"Delaval","year":"2005","journal-title":"Rev Pneumol Clin"},{"key":"10.1016\/j.ccm.2025.07.005_bib20","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1164\/ajrccm.163.2.2003146","article-title":"Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis","volume":"163","author":"Seymour","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib21","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.2214\/AJR.07.2402","article-title":"Silicoproteinosis: high-resolution CT findings in 13 patients","volume":"189","author":"Marchiori","year":"2007","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ccm.2025.07.005_bib22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1164\/rccm.200912-1800ED","article-title":"Pulmonary alveolar proteinosis associated with dust inhalation: not secondary but autoimmune?","volume":"181","author":"Costabel","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib23","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1164\/rccm.200708-1271OC","article-title":"Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan","volume":"177","author":"Inoue","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib24","first-page":"166","article-title":"[Pulmonary alveolar proteinosis]","volume":"19","author":"Briens","year":"2002","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.ccm.2025.07.005_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf9564","article-title":"Heterozygous OAS1 gain-of-function variants cause an autoinflammatory immunodeficiency","volume":"6","author":"Magg","year":"2021","journal-title":"Sci. Immunol"},{"issue":"2","key":"10.1016\/j.ccm.2025.07.005_bib26","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cell.2023.11.036","article-title":"Human inherited CCR2 deficiency underlies progressive polycystic lung disease","volume":"187","author":"Neehus","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ccm.2025.07.005_bib27","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ppul.20818","article-title":"Recurrent pulmonary alveolar proteinosis secondary to agammaglobulinemia","volume":"43","author":"Patiroglu","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.ccm.2025.07.005_bib28","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/thx.43.11.939","article-title":"Pulmonary alveolar lipoproteinosis complicating juvenile dermatomyositis","volume":"43","author":"Samuels","year":"1988","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2025.07.005_bib29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1440-1843.2006.00905.x","article-title":"Pulmonary alveolar proteinosis associated with a disease-modifying antirheumatoid arthritis drug","volume":"11","author":"Wardwell","year":"2006","journal-title":"Respirol. Carlton Vic"},{"key":"10.1016\/j.ccm.2025.07.005_bib30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1440-1843.2008.01450.x","article-title":"Pulmonary alveolar proteinosis in a patient with Behcet\u2019s disease","volume":"14","author":"Uchiyama","year":"2009","journal-title":"Respirol. Carlton Vic"},{"key":"10.1016\/j.ccm.2025.07.005_bib31","first-page":"90","article-title":"Pulmonary alveolar proteinosis: another autoimmune disease associated with sarcoidosis?","volume":"33","author":"Boerner","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.ccm.2025.07.005_bib32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/6809","article-title":"Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene","volume":"21","author":"Torrents","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.ccm.2025.07.005_bib33","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1172\/JCI117173","article-title":"A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds","volume":"93","author":"Nogee","year":"1994","journal-title":"J Clin Investig"},{"key":"10.1016\/j.ccm.2025.07.005_bib34","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1164\/ajrccm.161.3.9903153","article-title":"Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency","volume":"161","author":"Nogee","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJM200102223440805","article-title":"A mutation in the surfactant protein C gene associated with familial interstitial lung disease","volume":"344","author":"Nogee","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib36","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/thx.2007.083766","article-title":"Clinical, radiological and pathological features of ABCA3 mutations in children","volume":"63","author":"Doan","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2025.07.005_bib37","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/ppul.21289","article-title":"Surfactant protein C gene (SFTPC) mutation-associated lung disease: high-resolution computed tomography (HRCT) findings and its relation to histological analysis","volume":"45","author":"Mechri","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.ccm.2025.07.005_bib38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13023-021-01842-0","article-title":"Prospective study of the natural history of chronic acid sphingomyelinase deficiency in children and adults: eleven years of observation","volume":"16","author":"McGovern","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ccm.2025.07.005_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12890-015-0083-2","article-title":"GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders","volume":"15","author":"Griese","year":"2015","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib40","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2025.07.005_bib41","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.chest.2021.05.046","article-title":"Pulmonary manifestations of GATA2 deficiency","volume":"160","author":"Marciano","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2025.07.005_bib42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1164\/rccm.201301-0010LE","article-title":"Pulmonary alveolar proteinosis revealing a telomerase disease","volume":"188","author":"Marchand-Adam","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib43","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1164\/rccm.202112-2742SO","article-title":"Autoimmune pulmonary alveolar proteinosis","volume":"205","author":"McCarthy","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.alit.2015.12.005","article-title":"Increase in autoimmune pulmonary alveolar proteinosis after the 2011 Fukushima disaster","volume":"65","author":"Tanino","year":"2016","journal-title":"Allergol Int"},{"key":"10.1016\/j.ccm.2025.07.005_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10875-016-0364-4","article-title":"Disseminated cryptococcosis due to anti-granulocyte-macrophage colony-stimulating factor autoantibodies in the absence of pulmonary alveolar proteinosis","volume":"37","author":"Kuo","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ccm.2025.07.005_bib46","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/cid\/ciu968","article-title":"Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated\/extrapulmonary nocardiosis","volume":"60","author":"Rosen","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2025.07.005_bib47","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/MCP.0000000000000601","article-title":"Shaping the future of an ultra-rare disease: unmet needs in the diagnosis and treatment of pulmonary alveolar proteinosis","volume":"25","author":"McCarthy","year":"2019","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib48","doi-asserted-by":"crossref","first-page":"00314","DOI":"10.1183\/23120541.00314-2024","article-title":"Pulmonary fibrosis in patients with autoimmune pulmonary alveolar proteinosis: a retrospective nationwide cohort study","volume":"10","author":"Guirriec","year":"2024","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.ccm.2025.07.005_bib49","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00725-2024","article-title":"European respiratory society guidelines for the diagnosis and management of pulmonary alveolar proteinosis","volume":"64","author":"McCarthy","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2025.07.005_bib50","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/resp.13831","article-title":"Pulmonary alveolar proteinosis","volume":"25","author":"Jouneau","year":"2020","journal-title":"Respirol. Carlton Vic"},{"key":"10.1016\/j.ccm.2025.07.005_bib51","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2214\/ajr.176.5.1761287","article-title":"CT features of pulmonary alveolar proteinosis","volume":"176","author":"Holbert","year":"2001","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ccm.2025.07.005_bib52","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1378\/chest.09-0097","article-title":"Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis","volume":"136","author":"Ishii","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2025.07.005_bib53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1148\/radiology.211.1.r99ap10155","article-title":"Crazy-paving appearance at thin-section CT: spectrum of disease and pathologic findings","volume":"211","author":"Johkoh","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.ccm.2025.07.005_bib54","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.rmed.2011.08.018","article-title":"Pulmonary alveolar proteinosis: new insights from a single-center cohort of 70 patients","volume":"105","author":"Bonella","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib55","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.chest.2016.09.002","article-title":"Transbronchial cryobiopsy in diffuse parenchymal lung disease: retrospective analysis of 74 cases","volume":"151","author":"Ussavarungsi","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2025.07.005_bib56","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa062505","article-title":"GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis","volume":"356","author":"Uchida","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2466-14-37","article-title":"Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan","volume":"14","author":"Ishii","year":"2014","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib58","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood-2008-05-155689","article-title":"Granulocyte\/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects","volume":"113","author":"Uchida","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2025.07.005_bib59","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.leu.2405104","article-title":"High titer autoantibodies to GM-CSF in patients with AML, CML and MDS are associated with active disease","volume":"22","author":"Sergeeva","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.ccm.2025.07.005_bib60","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/thx.2005.054171","article-title":"Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis","volume":"61","author":"Lin","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2025.07.005_bib61","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/clim.2002.5301","article-title":"Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis","volume":"105","author":"Bonfield","year":"2002","journal-title":"Clin. Immunol. Orlando Fla"},{"key":"10.1016\/j.ccm.2025.07.005_bib62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF02715650","article-title":"Pulmonary alveolar proteinosis: prospective clinical experience in 23 patients for 15 years","volume":"162","author":"Kariman","year":"1984","journal-title":"Lung"},{"key":"10.1016\/j.ccm.2025.07.005_bib63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jshs.2023.10.010","article-title":"2024 Adult compendium of physical activities: a third update of the energy costs of human activities","volume":"13","author":"Herrmann","year":"2024","journal-title":"J. Sport Health Sci"},{"key":"10.1016\/j.ccm.2025.07.005_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2014.07.009","article-title":"A standardized blood test for the routine clinical diagnosis of impaired GM-CSF signaling using flow cytometry","volume":"413","author":"Kusakabe","year":"2014","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ccm.2025.07.005_bib65","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0064-2024","article-title":"Pathogenesis-driven treatment of primary pulmonary alveolar proteinosis","volume":"33","author":"Lettieri","year":"2024","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.ccm.2025.07.005_bib66","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0101-2024","article-title":"Rare genetic interstitial lung diseases: a pictorial essay","volume":"33","author":"Borie","year":"2024","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.ccm.2025.07.005_bib67","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1164\/rccm.200906-0978OC","article-title":"Inhaled granulocyte\/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis","volume":"181","author":"Tazawa","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib68","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1183\/09031936.00092910","article-title":"Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan","volume":"37","author":"Ishii","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2025.07.005_bib69","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-63-3-429","article-title":"Pulmonary alveolar proteinosis. endobronchial treatment","volume":"63","author":"Ramirez","year":"1965","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib70","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13023-016-0497-9","article-title":"Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures","volume":"11","author":"Campo","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ccm.2025.07.005_bib71","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1378\/chest.125.6.2351","article-title":"Enhanced alveolar clearance with chest percussion therapy and positional changes during whole-lung lavage for alveolar proteinosis","volume":"125","author":"Perez","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2025.07.005_bib72","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1183\/09031936.00017612","article-title":"Wash-out kinetics and efficacy of a modified lavage technique for alveolar proteinosis","volume":"40","author":"Bonella","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2025.07.005_bib73","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/LBR.0000000000000741","article-title":"Increased efficacy of whole lung lavage treatment in alveolar proteinosis using a new modified lavage technique","volume":"28","author":"Grutters","year":"2021","journal-title":"J. Bronchol. Interv. Pulmonol"},{"key":"10.1016\/j.ccm.2025.07.005_bib74","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1378\/chest.09-2295","article-title":"Whole-lung lavage for pulmonary alveolar proteinosis","volume":"136","author":"Michaud","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2025.07.005_bib75","first-page":"361","article-title":"Advances in the treatment of pulmonary alveolar proteinosis","volume":"111","author":"Kao","year":"1975","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ccm.2025.07.005_bib76","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1378\/chest.69.2.224","article-title":"Alveolar proteinosis. Lobar lavage by fiberoptic bronchoscopic technique","volume":"69","author":"Brach","year":"1976","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2025.07.005_bib77","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01982-2023","article-title":"Will inhalational GM-CSF replace whole lung lavage as a treatment for autoimmune pulmonary alveolar proteinosis? Many pole positions, not yet the final winner","volume":"63","author":"Bonella","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2025.07.005_bib79","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13023-020-01450-4","article-title":"Inhaled granulocyte-macrophage colony stimulating factor for mild-to-moderate autoimmune pulmonary alveolar proteinosis - a six month phase II randomized study with 24 months of follow-up","volume":"15","author":"Tian","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ccm.2025.07.005_bib80","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJMoa1816216","article-title":"Inhaled GM-CSF for pulmonary alveolar proteinosis","volume":"381","author":"Tazawa","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib81","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1056\/NEJMoa1913590","article-title":"Inhaled molgramostim therapy in Autoimmune pulmonary alveolar proteinosis","volume":"383","author":"Trapnell","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib82","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01233-2023","article-title":"Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients","volume":"63","author":"Campo","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2025.07.005_bib84","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1378\/chest.130.1.227","article-title":"An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis","volume":"130","author":"Venkateshiah","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2025.07.005_bib85","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1183\/09031936.00197710","article-title":"An open-label trial of rituximab therapy in pulmonary alveolar proteinosis","volume":"38","author":"Kavuru","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2025.07.005_bib86","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12931-018-0780-5","article-title":"Rituximab for auto-immune alveolar proteinosis, a real life cohort study","volume":"19","author":"Soyez","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.ccm.2025.07.005_bib87","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1183\/09031936.00097508","article-title":"Plasmapheresis for treatment of pulmonary alveolar proteinosis","volume":"33","author":"Luisetti","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2025.07.005_bib88","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12890-015-0085-0","article-title":"Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study","volume":"15","author":"Akasaka","year":"2015","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib89","first-page":"89","article-title":"Recurrence of pulmonary alveolar proteinosis after bilateral lung transplantation in a patient with a nonsense mutation in CSF2RB","volume":"19","author":"Takaki","year":"2016","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.ccm.2025.07.005_bib90","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jpeds.2004.04.047","article-title":"Recurrent fatal pulmonary alveolar proteinosis after heart-lung transplantation in a child with lysinuric protein intolerance","volume":"145","author":"Santamaria","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.ccm.2025.07.005_bib91","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2169\/internalmedicine.3770-19","article-title":"Secondary pulmonary alveolar proteinosis following treatment with azacitidine for myelodysplastic syndrome","volume":"59","author":"Hashimoto","year":"2020","journal-title":"Intern. Med. Tokyo Jpn"},{"key":"10.1016\/j.ccm.2025.07.005_bib92","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/RTI.0b013e3181930ed6","article-title":"Secondary pulmonary alveolar proteinosis: a confusing and potentially serious complication of hematologic malignancy","volume":"24","author":"Chung","year":"2009","journal-title":"J. Thorac. Imaging"},{"key":"10.1016\/j.ccm.2025.07.005_bib93","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ajh.10410","article-title":"Disseminated mycobacterium kansasii infection with pulmonary alveolar proteinosis in a patient with chronic myelogenous leukemia","volume":"74","author":"Goldschmidt","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ccm.2025.07.005_bib94","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/ajrccm.149.3.8118651","article-title":"Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients","volume":"149","author":"Cordonnier","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib95","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/ajh.10107","article-title":"Acquired pulmonary alveolar proteinosis after umbilical cord blood transplantation for acute myeloid leukemia","volume":"70","author":"Tomonari","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ccm.2025.07.005_bib96","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s12185-017-2375-1","article-title":"Hematopoietic stem cell transplantation for pulmonary alveolar proteinosis associated with primary immunodeficiency disease","volume":"107","author":"Tanaka-Kubota","year":"2018","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ccm.2025.07.005_bib97","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1182\/blood.2022017764","article-title":"The spectrum of GATA2 deficiency syndrome","volume":"141","author":"Calvo","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2025.07.005_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1225167","article-title":"A complicated case of whole-lung lavage: a case report","volume":"10","author":"Petrarulo","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.931153","article-title":"Allogeneic hematopoietic stem cell transplantation after prior lung transplantation for hereditary pulmonary alveolar proteinosis: a case report","volume":"13","author":"Beeckmans","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ccm.2025.07.005_bib100","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.ymthe.2019.06.010","article-title":"Long-term safety and efficacy of gene-pulmonary macrophage transplantation therapy of PAP in Csf2ra-\/- mice","volume":"27","author":"Arumugam","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.ccm.2025.07.005_bib101","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1172-5-32","article-title":"Lysinuric protein intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages","volume":"5","author":"Barilli","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ccm.2025.07.005_bib102","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01554-2021","article-title":"Methionine supplementation for multi-organ dysfunction in MetRS-related pulmonary alveolar proteinosis","volume":"59","author":"Hadchouel","year":"2022","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.ccm.2025.07.005_bib103","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.ajt.2024.03.003","article-title":"Successful lung transplantation in genetic MARS-related alveolar proteinosis\/lung fibrosis without recurrence under methionine supplementation:medium-term outcome in 4 cases","volume":"24","author":"Roy","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ccm.2025.07.005_bib104","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1589660","article-title":"Assessment of statin treatment for pulmonary alveolar proteinosis without hypercholesterolemia: a 12-month prospective, longitudinal, and observational study","volume":"2022","author":"Shi","year":"2022","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.ccm.2025.07.005_bib105","article-title":"Pioglitazone in pulmonary alveolar proteinosis: promising first clinical experience","volume":"78","author":"Dupin","year":"2020","journal-title":"Respir. Med. Res"},{"key":"10.1016\/j.ccm.2025.07.005_bib106","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature13807","article-title":"Pulmonary macrophage transplantation therapy","volume":"514","author":"Suzuki","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ccm.2025.07.005_bib107","doi-asserted-by":"crossref","first-page":"L438","DOI":"10.1152\/ajplung.00175.2021","article-title":"A murine model of hereditary pulmonary alveolar proteinosis caused by homozygous Csf2ra gene disruption","volume":"322","author":"Shima","year":"2022","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ccm.2025.07.005_bib108","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1164\/rccm.201306-1012OC","article-title":"Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosis","volume":"189","author":"Lachmann","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib109","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1164\/rccm.201306-1039OC","article-title":"Use of induced pluripotent stem cells to recapitulate pulmonary alveolar proteinosis pathogenesis","volume":"189","author":"Suzuki","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib110","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1164\/rccm.201810-1918IM","article-title":"Automated parenchymal pattern analysis of treatment responses in pulmonary alveolar proteinosis","volume":"199","author":"McCarthy","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2025.07.005_bib111","first-page":"101","article-title":"Quantitative evaluation of changes in three-dimensional CT density distributions in pulmonary alveolar proteinosis after GM-CSF inhalation","volume":"102","author":"Oda","year":"2023","journal-title":"Respir. Int. Rev. Thorac. Dis"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523125000607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523125000607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:56:41Z","timestamp":1760810201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523125000607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0272523125000607"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2025.07.005","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Alveolar Proteinosis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2025.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}